Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Skin substitutes & wound grafts · Massachusetts | Skin substitutes & wound grafts · New York | |
|---|---|---|
| Surgeons, 2024 | 33 | 70 |
| Medicare fee-for-service cases | 6,154 | 14,481 |
| Growth since 2019 (Medicare FFS) | +1.6%/yr | +3.3%/yr |
| Forecast cases (Medicare FFS) | 6,700 in 2030 | 20,500 in 2030 |
| Forecast growth | +1.4%/yr to 2030 | +5.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.7 | 4.7 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 36% (+13 pts since 2019) | 45% (+24 pts since 2019) |
| Cases per surgeon | 186 | 207 |
| Top 10 surgeons' share | 61% | 39% |
| Surgeons growing | 2 | 1 |
| New since the base year | 24 | 43 |
| Likely to stop billing it | 12 by 2026 | 34 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $12K | $20K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.